The CHIPS Act has created the largest demand signal for specialty chemicals in a generation. Whether your company captures it is an operational question, not a chemistry one, says Stephen Ottley, managing director and head of chemicals and pharmaceuticals at Maine Pointe
America’s semiconductor renaissance is underway. TSMC (Taiwan Semiconductor Manufacturing Company), the world’s largest contract chipmaker, is making advanced chips in Arizona. Intel has broken the 2nm barrier on US soil. Samsung is building a next-generation semiconductor manufacturing facility in Texas. Over $630 billion in announced private investment has been committed since 2020, according to the Semiconductor Industry Association.
Read the full article on specchemonline.com